title: A next-generation anti-IgE monoclonal?
authors: Clinical and Experimental Sciences and Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. g.c.roberts@soton.ac.uk.|NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK. g.c.roberts@soton.ac.uk.|The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, UK. g.c.roberts@soton.ac.uk.
authors: G
authors: G
authors: Roberts
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001249:Asthma / Q000821:virology*; D003233:Conjunctivitis, Allergic / Q000276:immunology / Q000628:therapy; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D000069444:Omalizumab / Q000627:therapeutic use*; D065631:Rhinitis, Allergic / Q000276:immunology / Q000628:therapy
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; C026408:anti-IgE antibodies; D000069444:Omalizumab; D007073:Immunoglobulin E